Gilead Sciences Current Affairs, GK & News

Zydus Cadila launched the cheapest generic version of Remdesivir in India

August 13, 2020

Zydus Cadila launched the cheapest generic version of Gilead Sciences’ antiviral drug Remdesivir in India to treat the deadly COVID 19 pandemic. The version has been launched after reports of a shortage of the drugs in the hospitals of the country. The price of drugs has been fixed as Rs 2800 per 100 mg vial. ..

Month: 

Category: 

Topics:  • • • • • •

European Union Signs Agreement with Gilead for Supply of Remdesivir

July 29, 2020

The European Union has reached an agreement with Gilead Sciences Inc. regarding the supply of the company’s antiviral drug Remdesivir to combat the deadly COVID 19 pandemic in the countries of the bloc. The deal of 63 million euros ($74 million) has been signed for procurement of Veklury, the brand name for Remdesivir which is ..

Month: 

Category: 

Topics:  • • • •

U.S. approves “Truvada”

July 21, 2012

The U.S. Food and Drug Administration showed green signal to an anti-HIV drug, Truvada, by pharmaceutical firm Gilead Sciences. It can now be used as prophylactic drug. However, many people are skeptic with the decision, particularly AIDS Healthcare Foundation (AHF).    What is Truvada? Tenofovir/emtricitabine, trademark Truvada by Gilead Sciences. Truvada is an anti-HIV drug. It ..

Month: 

Topics:  • • • • • • • • • •